{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PrP",
        "Protein_Change": {
          "ref": "A",
          "alt": "G",
          "position": "30"
        },
        "variant_string_id": "PrP A30G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Prion protein (PrP) is a key player in prion diseases. The A30G variant causes a conformational change that leads to abnormal protein folding and aggregation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to PrP misfolding and aggregation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "The paper uses Western blotting and immunohistochemistry to assess PrP expression levels and localization.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model and reflect the disease pathogenesis involving PrP.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Western blotting and immunohistochemistry were performed with appropriate controls and replicates.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that basic controls and multiple replicates were used.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The paper mentions using known pathogenic and benign PrP variants as controls.",
          "judgment": "Yes",
          "reasoning": "Variant controls were used, including known pathogenic and benign PrP variants.",
          "next_step_or_outcome": "Proceed to Step 4"
        }
      ]
    }
  ]
}